RE:hemorrhoid treatment devices marketThere are estimates much higher than 963.1 mn. How can revenue for O'Regan have diminished over time? The O'Regan revenue form this 3rd quarter report was not robust. Fact is the word robust was said only once in the transcript and that was about "dialogue" for specialty med services. Industry norms expect treatment growth rates near 5% with "banding" leading the way. The door needs to be pryed open for O'Regan because it's the MOST profitable portion of CRH MED!